Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 May;31(5):896-897.
doi: 10.1681/ASN.2019121340. Epub 2020 Apr 6.

The Value of Intravenous Iron: Beyond the Cave of Speculation

Affiliations
Editorial

The Value of Intravenous Iron: Beyond the Cave of Speculation

Daniel W Coyne et al. J Am Soc Nephrol. 2020 May.
No abstract available

Keywords: Hemodialysis hazards; anemia; cardiovascular events; infection.

PubMed Disclaimer

Comment on

References

    1. Fishbane S: Iron treatment: Impact of safety issues. Am J Kidney Dis 32[Suppl 4]: S152–S156, 1998 - PubMed
    1. Vaziri ND: Epidemic of iron overload in dialysis population caused by intravenous iron products: A plea for moderation. Am J Med 125: 951–952, 2012 - PubMed
    1. Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, et al. .; PIVOTAL Investigators and Committees: Intravenous iron in patients undergoing maintenance hemodialysis. N Engl J Med 380: 447–458, 2019 - PubMed
    1. Anker SD, Kirwan BA, van Veldhuisen DJ, Filippatos G, Comin-Colet J, Ruschitzka F, et al. .: Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: An individual patient data meta-analysis. Eur J Heart Fail 20: 125–133, 2018 - PubMed
    1. Macdougall IC, Bhandari S, White C, Farrington K, Kalra P, Mark P, et al. : Intravenous iron dosing and infection risk in hemodialysis patients: A pre-specified secondary analysis of the PIVOTAL trial. J Am Soc Nephrol 31: 1118–1127, 2020 - PMC - PubMed

LinkOut - more resources